Fundraising Fox
Protara Therapeutics
NASDAQ: TARAFounded 2017 · 66 employees on LinkedIn · 1 known investors
Find your way into Protara Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
1,010 people can intro you to Jesse
Ask Scott Braunstein to introduce you to Jesse Shefferman
You →Scott · together at Protara Therapeutics →Jesse
Sign up to find every way you can get introduced to Protara Therapeutics
- Your email: who you already know at Protara Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Protara Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
Founders & leadership
JS
Jesse SheffermanChief Executive OfficerCo-founder and CEO of Protara Therapeutics, Jesse Shefferman previously held business development and strategy roles at Retrophin and Vertex Pharmaceuticals, and worked as an investment banker at Barclays Capital and Lehman Brothers advising biopharmaceutical companies. He holds an MBA and Certificate in Health Sector Management from Duke University and a BA in Accounting from Gordon College.
WC
William ConklingChief Commercial Officer
LN
Leonardo NicacioChief Medical Officer
Investors · 1
Frequently asked questions
- What does Protara Therapeutics do?
- Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
- Who are Protara Therapeutics's investors?
- Protara Therapeutics's investors include Catalio Capital Management, LP.